BML Investment Partners, L.P. 13D/13G Filings for Athira Pharma, Inc. (ATHA)

BML Investment Partners, L.P. 13D and 13G filings for Athira Pharma, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-14
10:21 am
Purchase		 2024-12-31 13G Athira Pharma, Inc.
ATHA		 BML Investment Partners, L.P. 3,027,163
7.800%		 542,718increase
(+21.84%)		 Filing
2025-02-14
09:59 am
Unchanged		 2024-12-31 13G Athira Pharma, Inc.
ATHA		 BML Investment Partners, L.P. 2,484,445
6.500%		 0
(Unchanged)		 Filing
2024-11-07
1:15 pm
Purchase		 2024-11-01 13G Athira Pharma, Inc.
ATHA		 BML Investment Partners, L.P. 2,484,445
6.500%		 2,484,445increase
(New Position)		 Filing